[1] Mestan KK, Check J, Minturn L, et al.Placental pathologic changes of maternal vascular underperfusion in bronchopulmonary dysplasia and pulmonary hypertension[J].Placenta, 2014,35:570-574. [2] McEvoy CT, Jain L, Schmidt B, et al.Bronchopulmonary dysplasia:NHLBI workshop on the primary prevention of chronic lung diseases[J].Ann Am Thorac Soc, 2014, 11(Suppl 3):146-153. [3] Steinhorn R.When does BPD begin?[J].J Pediatr,2017;187:3. [4] Balany J, Bhandari V.Understanding the impact of infection, inflammation, and their persistence in the pathogenesis of bronchopulmonary dysplasia[J].Front Med,2015,2:90. [5] Etulain J, Mena HA, Negrotto S, et a1.Stimulation of PAR-1 or PAR-4 promotes similar pattern of VEGF and endostatin release and pro-angiogenic responses mediated by human platelets[J].Platelets, 2015, 26(8):799-804. [6] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].5版.北京.人民卫生出版社,2019:598. [7] Stoll BJ, Hansen NI, Bell EF, et al.Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012[J].JAMA,2015,314:1039-1051. [8] Morrow LA, Wagner BD, Ingram DA, et al.Antenatal determinants ofbronchopulmonary dysplasia and late respiratory disease in preterm infants[J].Am J Respir Crit Care Med, 2017,196:364-374. [9] Keller RL,Feng R, DeMauro SB, et al.Bronchopulmonary dysplasia and perinatal characteristics predict 1-year respiratory outcomes in newborns born at extremely low gestational age:a prospective cohort study[J].J Pediatr,2017,187:89-97. [10] Steinhorn R, Davis JM, Gopel W, et al.Chronic pulmonary insufficiency of prematurity:developing optimal endpoints for drug development[J].J Pediatr,2017,191:15-21. [11] Chu SG, Becker RC, Berger PB, et al.Mean platelet volume as a predictor of cardiovascular risk:a systematic review andmetaanalysis[J].J Thromb Haemost,2010,8:148-156. [12] Ilhan D, Ozbabalak D, Gulcan E, et al.Evaluation of platelet activation, coagulation, and fibrinolytic activation in patients with symptomatic lacunar stroke[J].Neurologist,2010,16:188-191. [13] 程萍,余增渊,孙慧清.平均血小板体积与新生儿坏死性小肠结肠炎预后不良的关系[J].中华新生儿科杂志,2019,34(6):453-455. [14] 孙慧清,李明超,余增渊,等.平均血小板体积与重度早产儿视网膜病的关系研究[J].中华新生儿科杂志,2019,34(1):29-33. [15] Cekmez F, Tanju IA, Canpolat FE, et al.Mean platelet volume in very preterm infants:a predictor of morbidities?[J].Eur Rev Med Pharmacol Sci,2013,17(1):134-137. [16] Dani C, Poggi C, Barp J, et al.Mean platelet volume and risk of bronchopulmonary dysplasia and intraventricular hemorrhage in extremely preterm infants[J].Am J Perinatol, 2011,28(7):551-556. [17] Chen X, Li H,Qiu X, et al.Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants[J].BMC Pediatr,2019,19(1):138. [18] Takahashi H, Shibuya M.The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions[J].Clin Sci (Lond),2005,109(3):227-241. [19] Voelkel NF, Vandivier RW, Tuder RM.Vascular endothelial growth factor in the lung[J].Am J Physiol Lung Cell Mol Physiol,2006,290(2):209-221. [20] Vieira-de-Abreu A, Campbell RA,Weyrich AS, et al.Platelets:versatile effector cells in hemostasis, inflammation, and the immune continuum[J].Semin Immunopathol,2012,34(1):5-30. [21] 付培培,谢萌,崔红.早产儿支气管肺发育不良形成过程中血小板动态监测[J].中国儿童保健杂志,2019,27(6):656-659. [22] 王又平,冯晋楠,李振宇,吕小明,蒋庆蕾,武辉.不同胎龄早产儿生后24 h内血小板及相关参数参考范围[J].中国当代儿科杂志,2020,22(7):696-700. |